Navigation Links
NanoInterventions Launches New, Rapid Testing System for Coronary Stents
Date:6/17/2008

pecial challenge for which its ElectroNanospray(TM) process is uniquely suited. Stentome, a partnership of cardiovascular scientists and bioengineers, led design of the mini-stent developed its current microfabrication process in Galway; and devised the complex surgical procedure for implanting the stent. Its scientific team contributes cutting edge expertise in cardiovascular medicine and molecular biology derived from ongoing, active research programs at Oxford and Stanford Universities. The University of Western Ontario, one of Canada's leading research-centered universities, contributes its robust drug-eluting polymer platform, which can be flexibly configured to deliver a broad range of drugs and biologics.

"We are thrilled to bring our operational and regulatory development expertise to this exciting venture and helping to establish it as a key new tool for the medical device, pharma/biotech and academic communities," commented Chris Pulling, CEO of The Integra Group. "NanoInterventions' synergistic technology and core competencies of research and engineering will save time and resources to bring more affordable, life-saving therapies to our health care system."

NanoInterventions is a featured company in the Positively Minnesota pavilion in the BIO International exhibition hall, from June 17-20, 2008.

For more information on this partnership or the medical device development process in general, please contact Ottar Schmitz at (763) 746-8899.


'/>"/>
SOURCE NanoInterventions
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ire-Asia/--NODPharmaceuticalsInc.announced,theUSPa...plicationfor,itsnano-particleoraldeliveryorNODtech...oachtoincorporatepeptidesor,proteinsintobio-adhesi...iseadministeredasinjections.NODtechnologyisaplatfo...rugssuchasinsulin,interferon,growthhormone,exenat...
(Date:11/24/2009)...ire-Asia/--ShanghaiBiolaxyannouncedthe,ChineseStat...nvestigationalnewdrugapplication(IND)foritsoralins...ntotreatdiabetes.ThisIND,approvalallowsBiolaxytoin...isadisordercharacteristicofhighbloodglucoseandpoor...nseveremicro-and,macro-vasculardiseases,lossofvisi...
(Date:11/24/2009)...BI recently approved the Promega PowerPlex 16 HS S...generating DNA records for the National DNA Index ... (PRWEB) -- The FBI recently approved the Promega ...ies participating in, or generating DNA records fo...ently contains more than seven million profiles an...
(Date:11/24/2009)...ORONTO,Nov.24/PRNewswire-FirstCall/-HamiltonThorne...gproviderofadvancedlasersystemsandinstrumentsforth...portedoperationalandfinancialresultsforthethirdqua...Revenuewas$1.46millioncomparedwith$1.43millioninQ3...6.1percentinQ3,2008,-Netlossreducedto$148,000compa...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...S (Generally Recognized As Safe) designation for S...ization in the U.S. and elsewhere - New collabora...383, - Initiation of safety studies to support re...(table sugar) Enhancer S6973, - Achievement of a m...tter blockers that improve the taste of hydr...
... Inc. (Nasdaq: ADLS ), a biopharmaceutical compan...cialization of novel drugs in the,therapeutic area...oday,announced its financial results for the third.../www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO ), ... the three months,ended September 30, 2008 was $13...
... (Nasdaq: PRXL ), a leading global biopharmaceuti...mpany is among the first to conduct a,Chinese brid...n providing,Asian bridging studies, which are cond...rmaceutical companies prepare strategic global pla...ave time and development costs for,programs in Asi...
Other Biology Technology:SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 2SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 3SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 4SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 5SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 6SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 7SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 8SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 9SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 10SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 11SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 12SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 13SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS 14Advanced Life Sciences Announces Third Quarter 2008 Financial Results 2Advanced Life Sciences Announces Third Quarter 2008 Financial Results 3Advanced Life Sciences Announces Third Quarter 2008 Financial Results 4Advanced Life Sciences Announces Third Quarter 2008 Financial Results 5Advanced Life Sciences Announces Third Quarter 2008 Financial Results 6Advanced Life Sciences Announces Third Quarter 2008 Financial Results 7Advanced Life Sciences Announces Third Quarter 2008 Financial Results 8Advanced Life Sciences Announces Third Quarter 2008 Financial Results 9Advanced Life Sciences Announces Third Quarter 2008 Financial Results 10Advanced Life Sciences Announces Third Quarter 2008 Financial Results 11PAREXEL Expands Pioneering Asian Ethnobridging Expertise 2PAREXEL Expands Pioneering Asian Ethnobridging Expertise 3PAREXEL Expands Pioneering Asian Ethnobridging Expertise 4PAREXEL Expands Pioneering Asian Ethnobridging Expertise 5
(Date:11/25/2009)...l Death Research Laboratory in the University of H... prestigious Johnson & Johnson Focused Funding gra...ell damage in Parkinson,s disease. The award, whic... innovation and excellence in science, was announc...month at an event at the Hyatt Regency Hotel in Ne...
(Date:11/25/2009)...professors recently received funding from the Nati... beneficial to understanding the environment. The ...wood, assistant professor in the Department of Bio...o separate research projects. , His first projec...s and Functions from the Leaf to the Landscape," w...
(Date:11/24/2009)...oday named 12 new grant recipients for 2009. The a... work across a broad spectrum of lupus research. A...d potential to drive scientific discovery to ultim... of systemic lupus. , The 2009 grants go to both...nation and include interdisciplinary and highly pr...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Aflex Unveils Revolutionary New Hose Design for the Chemical and Process Industry 5897 1Aflex Unveils Revolutionary New Hose Design for the Chemical and Process Industry 5897 2InteRNA Technologies and Dana Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways 60492 1InteRNA Technologies and Dana Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways 60492 2Vaporized Propylene Glycol a Key Ingredient in Electronic Cigarettes May Prevent Pneumonia Influenza and Other Respiratory Diseases 60489 1Vaporized Propylene Glycol a Key Ingredient in Electronic Cigarettes May Prevent Pneumonia Influenza and Other Respiratory Diseases 60489 2
...ing the network of genetic interactions promises t...cal landscape of the cell. The technology, which i...s already been used to assign new functions to kno...racterized proteins, and to define how biochemical... , E-MAP will enable new understanding of how gene...
...pression profile could help predict how patients w...herapy treatment. Described in a study in the Nove...logy (JCO), the new findings further establish an ...predictor of clinical outcome in ovarian cancer, a...ts into the mechanisms of drug resistance. , "In m...
...rom a study in Botswana, Harvard School of Public ...-1 subtype C in resource-poor settings, who receiv...able results to those in the developed world. A fu...astructure help ensure this success, according to ...al of Acquired Immune Deficiency Syndromes (JAIDS)...
Other Biology News:Technique offers new view of dynamic biological landscape 2Technique offers new view of dynamic biological landscape 3Technique offers new view of dynamic biological landscape 4Gene expression profile helps predict chemotherapy response in ovarian cancer patients 2Gene expression profile helps predict chemotherapy response in ovarian cancer patients 3Largest computational biology simulation mimics life’s most essential nanomachine 2
...estern Blot Strong Antibody Stripping Solution is ...lots that have been developed with chemiluminescen...not recommended for stripping colorimetric substra...t possible to effectively remove substrates that p...
...a 5x solution. Designed to dissociate and remove a...troying antigenic binding capacity. Recommended fo...als from blots. Not recommended for stripping colo...on sufficient to strip 25 - 30 standard blots. A s...
Marker for 2D Electrophoresis from Sigma-Aldrich
BAC End Sequencing from Seqwright
Biology Products: